Article

Low-grade myofibroblastic sarcoma of the larynx.

National Cancer Institute Regina Elena, Rome, Italy.
International Journal of Surgical Pathology (Impact Factor: 0.96). 02/2011; 19(6):822-6. DOI: 10.1177/1066896910393958
Source: PubMed

ABSTRACT Low-grade myofibroblastic sarcoma is an uncommon sarcoma with myofibroblastic differentiation. It occurs in a wide variety of sites and has a predilection for the head and neck region. Biologically, low-grade myofibroblastic sarcoma has a propensity for local recurrence and is associated with a low risk of metastatic spread. Histologically, it can mimic a variety of different types of benign and malignant processes and often requires immunohistochemical analysis for its accurate identification. This report describes a case and discusses the differential diagnosis of a low-grade myofibroblastic sarcoma that arose in the larynx of a 69-year-old woman with a history of metastatic skin melanoma. To the best of the authors' knowledge this is the first description in the English literature of low-grade myofibroblastic sarcoma originating in the larynx.

0 Bookmarks
 · 
127 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-grade myofibroblastic sarcoma (LGMS) is a distinct mesenchymal myofibroblastic malignancy. The tumor may occur at a variety of sites, but is particularly associated with the head and neck. Of the two maxillary sarcomas that were analyzed in the present study, one was misdiagnosed as an inflammatory myofibroblastic tumor during pre-operative excision biopsy, and later presented with a different immunophenotype upon recurrence. Representative paraffin blocks from formalin-fixed tissues were selected from each patient and designated as case 1 and case 2. Immunohistochemical studies were performed on 3-μm thick sections using primary antibodies against α-smooth muscle actin (α-SMA), muscle-specific actin (MSA), desmin, vimentin, calponin, h-caldesmon, fibronectin, cytokeratin, cluster of differentiation 34 (CD34), S-100 protein, anaplastic lymphoma kinase (ALK), epithelial membrane antigen (EMA) and Ki-67. Immunohistochemistry was performed using the streptavidin-biotin-peroxidase complex method. The tumor cells from the two maxillary LGMSs, including the recurrent lesion, were positive for vimentin and fibronectin, and negative for S-100 protein, CD34, EMA, h-caldesmon, ALK, MSA and calponin. The tumor cells from case 1 demonstrated positive staining for α-SMA protein and negative staining for desmin. By contrast, the tumor cells from the primary lesion in case 2 presented with negative staining for α-SMA and positive staining for desmin, while the cells of the recurrent lesion were α-SMA-positive and desmin-negative. The present study concluded that cases of LGMS with immunoprofile alterations are predictive of relatively poor prognoses.
    Oncology letters 02/2015; 9(2):619-625. DOI:10.3892/ol.2014.2790 · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We recently encountered a giant Myofibroblastic sarcoma (MS) exceeding 23 cm in diameter which had developed in the liver in a 27-year-old female, and which was surgically resected with gratifying results. On surveillance imaging, a giant mass was detected in the right lobe of the liver. One the basis of morphology and immunohistochemistry features, the diagnosis of intermediate-grade myofibroblastic sarcoma (MS) was established. MS is extremely rarely found in the abdominal cavity. It is almost impossible to make a definite diagnosis before operation. However, the possibility of sarcoma should be taken into account for liver mass according to multimodal imaging features of the mass, especially when the diagnosis of common hepatic tumor was not supported by signs on imaging. Relative characteristic features on multimodal images maybe helpful to considerate the possibility of MS. This is the first reported case to date.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-grade myofibroblastic sarcoma (LGMS) represents an atypical tumor composed of myofibroblasts with a predilection for the head and neck, especially in the tongue and oral cavity, with a high tendency to local recurrences and metastases, even after a long period. LGMS arising in the maxillary sinus and in the neck are extremely uncommon. To the best of our knowledge, only 50 cases of low-grade myofibroblastic sarcoma have been reported. We report two cases of LGMS of the maxillary sinus and neck, discussing clinical, histological, inmunohistochemical and therapeutic features.
    Revista Espanola de Cirugia Oral y Maxilofacial 11/2014; DOI:10.1016/j.maxilo.2013.04.004